This content is restricted.
Brief
Summary:
A completed investigation by the Competition Board has concluded that Neolife u00c4u00b0thalat u00c4u00b0hracat Au00c5u017e did not violate Article 4 of the Act no 4054 on the Protection of Competition through resale price maintenance and restricting buyers' online sales. The investigation, initiated in 2023, was terminated after the party accepted a settlement text submitted in accordance with the Competition Board's decision. This decision was made possible through the settlement procedure, which allows for a rapid resolution of the investigation process and may arise from procedural benefits. The full decision text is available for reference and can be appealed before the Ankara Administrative Courts.
Highlights content goes here...
This content is restricted.
